Cigna Not Pursuing Humana Merger, Stock Soars

On Monday, Cigna Group (NYSE:CI) said its officials are expected to participate in meetings with investors and analysts over the next several weeks.

Additionally, in light of recent and persistent speculation, Cigna confirmed that it is not pursuing a combination with Humana Inc. (NYSE:HUM).

“The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are strategically aligned, financially attractive, and have a high probability to close,” the company added.

During these meetings, Cigna expects to reaffirm its projected full-year 2024 consolidated adjusted EPS outlook of at least $28.40 per share and growth of at least 10% in 2025.

In October, the company reported third-quarter sales of $63.7 billion, ...